About OxyPrem
OxyPrem is a Healthcare company based in Zurich (Switzerland) founded in 2018. A non-invasive device for measuring brain oxygen levels is developed. OxyPrem has raised $130.75 thousand across 3 funding rounds from investors including European Union, EIC Fund and Venture Kick. OxyPrem offers products and services including OxyPrem 1.4 and NOAH. Its focus areas include Life Sciences, Pediatrics, Medical Devices and Screening. Its legal entity is OxyPrem AG.
Company details
OxyPrem was founded in 2018 in Zurich, Switzerland, within the medical device sector. A non-invasive, reusable tissue oximeter is developed by the company, utilizing near-infrared spectroscopy (NIRS) to detect and monitor hemoglobin oxygen saturation in tissues in real time. Operations focus on brain oxymetry applications, with the technology designed for repeated use across various clinical settings.
- Headquarters Zurich, Switzerland
- SectorsHealthcare
- Website oxyprem.com
- Social LinkedIn
- Legal Name Oxyprem Ag
- Total Equity Funding$130.75K (USD)
in 3 rounds
- Latest Funding Round$55.02K (USD), Grant
Feb 2020
- InvestorsEuropean Union
& 2 more
Products & Services of OxyPrem
OxyPrem offers a comprehensive portfolio of products and services, including OxyPrem 1.4 and NOAH.
Device for high-precision brain oxygen monitoring in newborns.
Tool summarizing neonatal challenges and oxygen level insights.
Funding Insights of OxyPrem
OxyPrem has successfully raised a total of $130.75K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $55.02 thousand completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $130,754
- Total Rounds 3
- Last Round Grant — $55,020
- First Round $130,754
(Aug 2019)
- Investors Count 3
All 3 funding rounds of OxyPrem with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2020 | $55,020 | Grant | – | – | |
| Nov 2019 | $55,952 | Grant | – | – | |
| Aug 2019 | $130,754 | Seed | – | Venture Kick | – |
3 investors in total: 3 institutional.
Investors in OxyPrem
OxyPrem has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
University backed startup accelerator | venturekick.ch | Schlieren, Switzerland | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for OxyPrem
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of OxyPrem
3 dated milestones of OxyPrem across 2 years, from founding to its latest funding, stage changes and deals.
- Founded OxyPrem is founded.
- Funding First funding round of $131K.
- Funding Latest funding round, Grant, of $55K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OxyPrem
OxyPrem was founded in 2018 and raised its 1st funding round 1 year after it was founded.
OxyPrem is headquartered in Zurich, Switzerland.
OxyPrem is a funded company, having raised a total of $130.75K across 3 funding rounds to date. The company's 1st funding round was a Seed of $130.75K, raised on Aug 2019.
OxyPrem was founded in 2018 in Zurich, Switzerland, within the medical device sector. A non-invasive, reusable tissue oximeter is developed by the company, utilizing near-infrared spectroscopy (NIRS) to detect and monitor hemoglobin oxygen saturation in tissues in real time. Operations focus on brain oxymetry applications, with the technology designed for repeated use across various clinical settings.
OxyPrem offers OxyPrem 1.4 and NOAH.
OxyPrem has 3 investors. Key investors include European Union, EIC Fund, and Venture Kick.
OxyPrem operates through Oxyprem Ag.